Search results
Results from the WOW.Com Content Network
Lactulose is commonly prescribed for children who develop fear of their bowel movements and are withholders. This is because lactulose, when dosed in the proper amount, causes a bowel movement that is impossible to retain for very long. Lactulose is also used for the elderly because of its gentle and consistent results. [medical citation needed]
In other words, as many as 4 million people in the U.S. who currently take statins for primary prevention — meaning they have not had a cardiovascular event such as a stroke or heart attack ...
Statins are effective and considered safe for most people, but they raise the risk of side effects, including muscle aches, liver problems, mental fuzziness and the potential for developing diabetes.
[4] [23] Lactulose does not appear to be more effective than lactitol for treating people with hepatic encephalopathy. [23] Side effects of lactulose and lactitol include the possibility of diarrhea, abdominal bloating, gassiness, and nausea. [23] In acute liver failure, it is unclear whether lactulose is beneficial.
Red yeast rice [10] is the natural source from which statins were discovered, but the FDA currently disallows any RYR with significant amounts of statin to be sold as a dietary supplement [11] Boswellia serrata [12] L-arginine may enhance the effects of a Statin, but will not lead to a reduction in cholesterol alone. [13] Flaxseed oil [14]
Dulled mood and personality effects on a GLP-1 are “likely related to overly suppressing pleasure pathways that are in the brain,” says Dr. Kumar. While most often suppressing these pathways ...
Lactulose is a carbohydrate that is not absorbed by humans. Lactulose is well known to measure oro-cecal transit time. [11] [1] [4] The mean oro-cecal transit time in normal healthy individuals is 70 to 90 minutes. [12] [13] [8] By 90 minutes, at least 50% of individuals would have delivered the lactulose dose to the colon. Approximately 90 to ...
Torcetrapib (CP-529,414, Pfizer) was a drug being developed to treat hypercholesterolemia (elevated cholesterol levels) and prevent cardiovascular disease.Its development was halted in 2006 when phase III studies showed excessive all-cause mortality in the treatment group receiving a combination of atorvastatin (Lipitor) and torcetrapib.